Riskpilot← Back to searchSign inGet full accessDr.Dogan AB
ABActiveOrg 5591664650Bataljonsgatan 2 CGeneral medical practice activities · NACE 8621Est. 20181-4 employees
Revenue 2025
SEK 1M
-45% vs 2024
EBITDA margin
11.0%
-89% vs 2024
Equity ratio
96.0%
Financial strength
Net profit 2025
SEK 86K
-89% vs 2024
| Revenue | SEK 1M | -45% |
| EBITDA | SEK 110K | -89% |
| Net profit | SEK 86K | -89% |
| Total assets | SEK 2,3M | -6% |
| Equity | SEK 2,2M | -5% |
| Employees | — | — |
Legal name
Dr.Dogan AB
Org number
5591664650
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
20 juli 2018
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Primärvårdsmottagningar med läkare. Konsultläkare som innefattar sjukvårdstjänster.
Address
Bataljonsgatan 2 C
Email
sinandogan88@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 814 | 1 093 | 1 059 | 1 837 | 1 004 |
| Staff expenses | — | −1 | — | −255 | −159 |
| EBITDA | 791 | 1 001 | 849 | 1 004 | 110 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 791 | 1 001 | 849 | 1 004 | 110 |
| Net financials | — | 0 | −1 | −4 | 1 |
| Profit before tax | 791 | 1 001 | 847 | 999 | 111 |
| Tax | −188 | −206 | −181 | −209 | −25 |
| Net profit | 603 | 795 | 666 | 790 | 86 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 875 | 1 652 | 1 995 | 2 488 | 2 333 |
| Equity | 650 | 1 279 | 1 765 | 2 355 | 2 241 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 225 | 373 | 230 | 132 | 92 |
| Total debt | 225 | 373 | 230 | 132 | 92 |
EBITDA margin
11.0%
This company
15.8%
Market median
-30% vs market
20212025
Equity ratio
96.0%
This company
38.2%
Market median
+151% vs market
20212025
Return on equity
3.8%
This company
18.4%
Market median
-79% vs market
20212025
Net profit margin
8.5%
This company
8.1%
Market median
+5% vs market
20212025
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-06-01 – 2025-05-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-06-01 – 2024-05-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-06-01 – 2023-05-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-06-01 – 2022-05-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-06-01 – 2021-05-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr.Dogan AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sinan Dogan | Board of Directors | 0 companies |
| Trifa Ibrahim Dogan | Deputy Board Member | 0 companies |
| Berivan Dogan Bozan | Deputy Board Member | 0 companies |
| Hamdi Robert Magdy-Ali Refai | Deputy Board Member | 0 companies |